A gene tied to living longer in one kind of childhood brain tumor
Original title: The neuronal plasticity gene CRTC1 links survival with mitochondrial programs and tumor microenvironment features in Group 3 β medulloblastoma
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only a study of gene data, not a test of any treatment in people.
The short version
A gene called CRTC1 may mark which medulloblastoma tumors behave differently.
What was studied. Researchers used gene data that had already been collected from other studies. They checked a gene called CRTC1 in the growing cerebellum and in brain tumors in children.
What they found. Of the childhood brain tumors looked at, medulloblastoma had the most CRTC1, and levels were highest in Group 4. In the subtype called Group 3 beta, more CRTC1 went along with living longer, and this held up when all 12 subtypes were checked. In those same tumors, more CRTC1 went along with less activity in the parts of cells that make energy.
What this means, and what it doesn't
What it could mean: CRTC1 might someday help doctors tell which of these tumors act differently from others. Right now it is a clue for more research, not a test or a treatment.
What it doesn't mean: This does not mean there is a new treatment, and it is not a cure. No one was given a drug here. The team only looked at gene data already gathered from past studies. It does not change the care a patient gets today. Much more work is needed to know if this gene really matters.
Source: bioRxiv (preprint), October 7, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.